Continuous and Intermittent Glucose Monitoring in 2021

Hartmann-boyce J , Rees K , Perring JC , Kerneis SA , Morris EM , Goyder C , et al. Risks of and from SARS-CoV-2 infection and COVID-19 in people with diabetes: A systematic review of reviews. Diabetes Care, 2021; 44: 2790–2811.

Barrett CE , Park J , Kompaniyets L , Baggs J , Cheng YJ , Zhang P , et al. Intensive care unit admission, mechanical ventilation, and mortality among patients with type 1 diabetes hospitalized for COVID-19 in the U.S. Diabetes Care, 2021; 44: 1788–1796.

Noor N , Ebekozien O , Levin L , Stone S , Sparling DP , Rapaport R , et al. Diabetes technology use for management of type 1 diabetes is associated with fewer adverse COVID-19 outcomes: Findings from the T1D exchange COVID-19 surveillance registry. Diabetes Care, 2021; 44: e160–e162.

Agarwal S , Mathew J , Davis GM , Shephardson A , Levine A , Louard R , et al. Continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic. Diabetes Care, 2021; 44: 847–849.

Faulds ER , Boutsicaris A , Sumner L , Jones L , McNett M , Smetana KS , et al. Use of continuous glucose monitor in critically ill COVID-19 patients requiring insulin infusion: an observational study. J Clin Endocrinol Metab, 2021; 106: e4007–e4016.

Karter AJ , Parker MM , Moffet HH , Gilliam LK , Dlott R . Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes. JAMA, 2021; 325: 2273–2284.

Foster NC , Beck RW , Miller KM , Clements MA , Rickels MR , Dimeglio LA , et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther, 2019; 21: 66–72.

Pettus JH , Zhou FL , Shepherd L , Preblick R , Hunt PR , Paranjape S , et al. Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in U.S. adult patients with type 1 diabetes: A real-world study. Diabetes Care, 2019; 42: 2220–2227.

Šuput Omladič J , Slana Ozimič A , Vovk A , Šuput D , Repovš G , Dovc K , et al. Acute hyperglycemia and spatial working memory in adolescents with type 1 diabetes. Diabetes Care, 2020; 43: 1941–1944.

Foland-Ross LC , Tong G , Mauras N , Cato A , Aye T , Tansey M , White NH , Weinzimer SA , Englert K , Shen H , Mazaika PK RADR in CN (DirecNet). Brain function differences in children with type 1 diabetes: A functional MRI study of working memory. Diabetes, 2020; 69: 1770–1778.

Sanderson EE , Abraham MB , Smith GJ , Mountain JA , Jones TW , Davis EA . Continuous glucose monitoring improves glycemic outcomes in children with type 1 diabetes: Real-world data from a population-based clinic. Diabetes Care, 2021; 44: e171–e172.

Gerhardsson P , Schwandt A , Witsch M , Kordonouri O , Svensson J , Forsander G , et al. The SWEET project 10-year benchmarking in 19 countries worldwide is associated with improved HbA1c and increased use of diabetes technology in youth with type 1 diabetes. Diabetes Technol Ther, 2021; 23: 491–499.

Mauras N , Buckingham B , White NH , Tsalikian E , Weinzimer SA , Jo B , et al. Impact of type 1 diabetes in the developing brain in children: A longitudinal study. Diabetes Care, 2021; 44: 983–992.

Laffel LM , Kanapka LG , Beck RW , Bergamo K , Clements MA , Criego A , et al. Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: A randomized clinical trial. JAMA, 2020; 323: 2388–2396.

Da Silva J , Lepore G , Battelino T , Arrieta A , Castañeda J , Grosman B , et al. Real-world performance of the MiniMed ^TM 780G system: First report of outcomes from 4,120 users. Diabetes Technol Ther 2021 Sep 15. doi: 10.1089/dia.2021.0203. Online ahead of print.

Hásková A , Radovnická L , Petruželková L , Parkin CG , Grunberger G , Horová E , et al. Real-time CGM is superior to flash glucose monitoring for glucose control in type 1 diabetes: The corrida randomized controlled trial. Diabetes Care, 2020; 43: 2744–2750.

Nimri R , Battelino T , Laffel LM , Slover RH , Schatz D , Weinzimer SA , et al. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes. Nat Med, 2020; 26: 1380–1384.

Phillip M , Bergenstal RM , Close KL , Danne T , Garg S , Heinemann L , et al. The digital/virtual diabetes clinic: The future is now—recommendations from an international panel on diabetes digital technologies introduction. Diabetes Technol Ther, 2021; 23: 146–154.

Charleer S , De Block C , Van Huffel L , Broos B , Fieuws S , Nobels F , et al. Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): A prospective observational real-world cohort study. Diabetes Care, 2020; 43: 389–397.

Polonsky WH , Fortmann AL . Impact of real-time CGM data sharing on quality of life in the caregivers of adults and children with type 1 diabetes. J Diabetes Sci Technol 2020 Dec 16; 1932296820978423. doi: 10.1177/1932296820978423. Online ahead of print.

Aleppo G , Beck RW , Bailey R , Ruedy KJ , Calhoun P , Peters AL , et al. The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin. Diabetes Care, 2021; 44: 2927–2737.

Khunti K , Prato S Del , Mathieu C , Kahn SE , Gabbay RA , Buse JB . Covid-19, hyperglycemia and new-onset diabetes. Diabetes Care, 2021; 44: 2645–2655.

Rodbard D . Quality of glycemic control: Assessment using relationships between metrics for safety and efficacy. Diabetes Technol Ther, 2021; 23: 692–704.

Karter AJ , Parker MM , Moffet HH , Gilliam LK , Dlott R . Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes. JAMA, 2021; 325: 2273–2284.

Perkins BA , Sherr JL , Mathieu C . Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation. Science, 2021; 373: 522–527.

Ceriello A , Prattichizzo F , Phillip M , Hirsch IB , Mathieu C , Battelino T . Review glycaemic management in diabetes: Old and new approaches. Lancet Diabetes Endocrinol, 2022; 10: 75–84.

Addala A , Auzanneau M , Miller K , Maier W , Foster N , Kapellen T , et al. A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: A transatlantic comparison. Diabetes Care, 2021; 44: 133–140.

Akturk HK , Agarwal S , Hoffecker L , Shah VN . Inequity in racial-ethnic representation in randomized controlled trials of diabetes technologies in type 1 diabetes: Critical need for new standards. Diabetes Care, 2021; 44: e121–123.

Walker AF , Hood KK , Gurka MJ , Filipp SL , Anez-Zabala C , Cuttriss N , et al. Barriers to technology use and endocrinology care for underserved communities with type 1 diabetes. Diabetes Care, 2021; 44: 1480–1490.